The results revealed a significant increase in plasma Resistin levels and in CAP1 expression in peripheral blood mononuclear cells of coronary artery disease patients, suggesting that Resistin is able to exert its effects stronger on cells with up-regulated CAP1 (Munjas et al., 2017). The gene discussed is CAP1; the disease is coronary artery disorder.